Complement Activation
1. Biological Effect: Hemocompatibility Tests
2. Turnaround time: 6 weeks
3. Sample Requirements:
ISO
30 cm² (test item < 0.5 mm thick);
18 cm² (test item ≥ 0.5 mm thick);
1 gram;
5 ml;
at least 3 test items;
ISO 10993-4
The purpose of the study is to determine the potential for the medical device to activate the Complement system in human plasma. The test item is exposed to human plasma and the concentration of SC5b-9 is then analysed by ELISA. The results after exposure to the medical device are compared with those of negative and untreated controls.
How We Work
Discovery & Insight
We begin with an in-depth consultation to understand your needs, challenges, and objectives. This helps us define the right strategy and scientific approach for your project.
Design & Development
Our experts translate your vision into actionable plans — combining innovative research, data, and technology to build precise and reliable solutions.
Delivery & Support
We implement the solution with full transparency and ongoing communication. After delivery, we stay involved — supporting you with optimization, updates, and future improvements.
Contact with us
We’re open to collaboration and research partnerships. Fill out the form — our team will respond as soon as possible.
Location:
Europejski Instytut Biomedyczny sp. z o.o.
ul. Bartycka 63A lok. 6, 00-716 Warszawa
Mail:
contact@ebi.bio
Phone:
+48 22 780 06 32
Get in touch
